相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
TRANSLATIONAL MEDICINE Cancer lessons from mice to humans
David Tuveson et al.
NATURE (2011)
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis (vol 8, pg 210, 2011)
John M. L. Ebos et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas
G. Kloeppel et al.
PATHOLOGE (2010)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas
L. Fischer et al.
BRITISH JOURNAL OF SURGERY (2008)
Neuroendocrine Tumor Epidemiology Contrasting Norway and North America
Oyvind Hauso et al.
CANCER (2008)
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
David C. Metz et al.
GASTROENTEROLOGY (2008)
Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors
Anne O'Donnell et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Activity of sunitinib in patients with advanced neuroendocrine tumors
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas
Marie-Louise Fjallskog et al.
ACTA ONCOLOGICA (2007)
Maximizing mouse cancer models
Kristopher K. Frese et al.
NATURE REVIEWS CANCER (2007)
Molecular basis for sunitinib efficacy and future clinical development
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization
F Panzuto et al.
ENDOCRINE-RELATED CANCER (2005)
A multitargeted, metronomic, and maximum-tolerated dose chemo-switch regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer
K Pietras et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas
MA Kouvaraki et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors
AD McCollum et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression
DE Hansel et al.
MODERN PATHOLOGY (2003)
VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis
M Inoue et al.
CANCER CELL (2002)
分享论文
